The Enhanced Organic Acids Test Report: A Practitioner’s Guide to Smarter Interventions

Overview

Join the clinical team from MosaicDX for a webinar unveiling the enhanced Organic Acids Test (OAT). This discussion brings together Chief Medical Officer Kurt N. Woeller, DO; Senior Manager of Clinical Development Michelle Maddux, ND; and Manager of Clinical Development Lindsay Goddard, MS, RD, LD/N for an in-depth look at the latest enhancements and how this launch supports meaningful interpretation in a simple-to-review format.

The OAT has long been a cornerstone of functional medicine, offering a comprehensive snapshot of nutritional, gastrointestinal, and metabolic health. In this session, our panel will explore how the updated report improves data interpretation, streamlines practitioner workflows, and enhances patient understanding. You’ll gain a deeper appreciation for the OAT’s clinical applications in identifying components of complex health concerns—from mitochondrial dysfunction and gut dysbiosis to nutrient deficiencies, toxic exposure, and detoxification imbalances.

Objectives

After attending this session, participants will be able to:

• Describe the new features and structure of the updated Organic Acids Test report.
• Explain how OAT biomarkers provide insight into core biochemical pathways and patient health trends.
• Integrate OAT findings into comprehensive functional medicine assessments and treatment planning.
• Understand how MosaicDX’s updated report supports both clinical efficiency and patient education.